Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 70 of 95, showing 5 Applications out of 474 total, starting on record 346, ending on 350

# Protocol No Study Title Investigator(s) & Site(s)

346.

ECCT/16/07/02   A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events
    A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events   
Principal Investigator(s)
1. Mark Loeb
Site(s) in Kenya
The Aga Khan University Hospital
 
View

347.

ECCT/16/07/01   VAC52150EBL4001
    A Multi-country, prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines AD26.ZEBOV and or/ MVA-BN-Filo   
Principal Investigator(s)
1. Omu Anzala
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. Kenya medical Research Institute/Walter Reed Project Kombewa (Kisumu county)
3. Kenya medical Research Institute/Walter Reed Project Kombewa (Kericho county)
 
View

348.

ECCT/17/04/01   Odón Device for assisted vaginal delivery
    Feasibility, safety and preliminary efficacy study of a new device (Odón  Device) for assisted vaginal delivery   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
Kenyatta National Hospital
 
View

349.

ECCT/16/07/05   HESTIA 1
    Multicentre, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric patients with sickle cell disease   
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
3. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children’s Hospital (Nairobi City county)
2. Kemri CRDR research center at Chandaria Health Centre Dagoretti (Nairobi City county)
3. Clinical Research Annex at the Siaya County Referral Hospital (Siaya county)
4. Kondele Children’s Hospital, KEMRI – Centre for Clinical Research (Kisumu county)
 
View

350.

ECCT/16/09/02   Monitoring Pre-Exposure Prophylaxis for Young Adult Women ( (MPYA)
    Next generation real-time monitoring for PrEP adherence in young adult women.   
Principal Investigator(s)
1. Prof. Elizabeth Anne Bukusi Bukusi
2. Dr. Stella Njuguna Njuguna
Site(s) in Kenya
1. KISUMU SITE (Kisumu county)
 
View